Jan Rosier
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 10
-
- Biochemical and Molecular Research 3
- DNA Repair Mechanisms 2
- Co-authors
- Laurent Schueller (8 shared papers)Carlos H. Van Peteghem (3 shared papers)Lieven Baert (9 shared papers)Gerben van ‘t Klooster (5 shared papers)Carlos Van Peteghem (6 shared papers)P. Van Remoortere (3 shared papers)Piet Wigerinck (3 shared papers)M. Vanhoorne (5 shared papers)
- Journals
- European Journal of Pharmaceutics and Biopharmaceutics (5 papers)International Archives of Occupational and Environmental Health (3 papers)Drug Information Journal (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Pharmaceutical Development and Technology (1 paper)
- Partner nations
- BelgiumIrelandNetherlands
In The Last Decade
Jan Rosier
29 papers receiving 632 citations
Peers
Comparison fields: 5 of 112
- Pharmaceutical Science 189
- Virology 74
- Infectious Diseases 125
- Biomaterials 76
- Analytical Chemistry 34
Countries citing papers authored by Jan Rosier
This map shows the geographic impact of Jan Rosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Rosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Rosier more than expected).
Fields of papers citing papers by Jan Rosier
This network shows the impact of papers produced by Jan Rosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Rosier. The network helps show where Jan Rosier may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Rosier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 185 | |
| 2 | 2016 | 90 | |
| 3 | 2009 | 43 | |
| 4 | 2009 | 41 | |
| 5 | 1988 | 38 | |
| 6 | 1982 | 23 | |
| 7 | 2016 | 23 | |
| 8 | 2009 | 23 | |
| 9 | 1987 | 22 | |
| 10 | 2001 | 22 | |
| 11 | 1989 | 21 | |
| 12 | 2008 | 15 | |
| 13 | 2001 | 15 | |
| 14 | 2019 | 13 | |
| 15 | 1984 | 13 | |
| 16 | 2003 | 12 | |
| 17 | 1988 | 11 | |
| 18 | 2008 | 10 | |
| 19 | 2010 | 9 | |
| 20 | 1983 | 8 |
About Jan Rosier
Jan Rosier is a scholar working on Infectious Diseases, Molecular Biology, Pharmaceutical Science, Strategy and Management and Oncology, having authored 31 papers that have together received 667 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), Drug Solubulity and Delivery Systems (6 papers), Innovation and Knowledge Management (3 papers), Advanced Drug Delivery Systems (3 papers), Biochemical and Molecular Research (3 papers), Body Composition Measurement Techniques (2 papers), DNA Repair Mechanisms (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmaceutical Science (189 citations), Virology (74 citations), Infectious Diseases (125 citations), Biomaterials (76 citations) and Analytical Chemistry (34 citations). Jan Rosier has collaborated with scholars based in Belgium, Ireland and Netherlands. Frequent co-authors include Laurent Schueller, Carlos H. Van Peteghem, Lieven Baert, Gerben van ‘t Klooster, Carlos Van Peteghem, P. Van Remoortere, Piet Wigerinck, M. Vanhoorne, Koen Iterbeke and Guenter Kraus. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, International Archives of Occupational and Environmental Health, Drug Information Journal, European Journal of Pharmaceutical Sciences and Pharmaceutical Development and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.